The Asia Pacific single-use bioprocessing systems market has been anticipated in an intelligence report by Transparency Market Research (TMR) to roll out a highly competitive vendor landscape in the foreseeable future. This could be on account of a substantial pool of regional as well as multinational companies. As a result, the market has been prognosticated to render an exceedingly dynamic characteristic. However, product differentiation could moderately water down the level of competition in the market.
In 2015, an estimated eight companies had secured a whopping 95.0% share in the Asia Pacific single-use bioprocessing systems market, viz. Sartorius AG, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corp., Saint Gobain, Corning, Inc., and Parker Hannifin Corp.
The TMR report has foreseen the Asia Pacific single-use bioprocessing systems market to earn a valuation of US$1.4 bn by the end of 2024 from US$0.4 bn in 2015 at a decent CAGR of 12.50% for the forecast period 2016–2024. The pharmaceutical industry could top the market on the basis of end use, considering its 34.5% share in 2015 and several factors fueling growth. With a 33.0% share achieved in the same year, China has been prophesied to be another opportunity to cash in on until the concluding forecast year.
Cost Effectiveness and Low Capital Investment for Deployment Secure High Growth
The Asia Pacific single-use bioprocessing systems market has been expected to gain a significant demand among prime end users such as academic and research institutes, contract research organizations (CROs) and contract manufacturing organizations (CMOs), biotechnology, and pharmaceutical. This could be because of the decidedly cost-effective nature of single-use bioprocessing systems. The capital cost of retrofitting and building biopharmaceutical manufacturing facilities could be decreased with the employment of single-use bioprocessing systems. Compared to stainless steel products, single-use bioprocessing equipment could be deployed with a low initial capital investment.
Other factors that have been envisaged to set the tone for a constant growth in the Asia Pacific single-use bioprocessing systems market include the reduced time consumed by clean-in-place (CIP) and sterilize-in-place (SIP) processes.
Environmental Worries and Technical Problems Neutralize Demand
Despite the aforementioned driving factors projected to be prevalent in the Asia Pacific single-use bioprocessing systems market, industry players could be challenged with environmental concerns associated with the engagement of disposables and certain technical difficulties. Moreover, lack of awareness about innovative disposable applications in bioproduction and rigorous government regulations related to the deployment of disposable systems and issues linked to the employment of plastic-based disposable products have been forecasted to be other restraining factors of the Asia Pacific single-use bioprocessing systems market.
However, technological advancement, initiatives to inform end users about various benefits of using single-use bioprocessing systems, and appropriate training programs could help the market to rise above its challenges. Besides this, mushrooming geriatric population, improving healthcare and medical infrastructure, increasing healthcare expenditure, and continuing occurrence of cancer have been envisioned to offer profit-making prospects in the Asia Pacific single-use bioprocessing systems market.
Key markets such as China could augment the demand in the market on the back of advancing biotechnology and pharmaceutical sectors, rising emergence of new products, and snowballing need for preassembled and cost-efficient modular bioprocessing plants.
The information presented in this review is based on a TMR report, titled, “Single-use Bioprocessing Systems Market (Product - Bioreactors, Mixers, Bags, Bioprocess Containers, Filtration Devices, Tubing, Sampling Systems, Connectors and Clamps, and Probes and Sensors; End User - Pharmaceutical, Biotechnology, CRO and CMO, and Academic and Research Institutes; Application - Vaccine Production, Biosimilar Production, Blood Plasma Products, Cell Therapy, and Biopharma Products) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The Asia Pacific Single-use Bioprocessing Systems Market has been segmented as presented below:
Asia Pacific Single-use Bioprocessing Systems Market by Product
- Bioprocess Containers
- Filtration Devices
- Sampling Systems
- Connectors and Clamps
- Probes and Sensors
Asia Pacific Single-use Bioprocessing Systems Market by End User
- CRO and CMO
- Academic and Research Institutes
Asia Pacific Single-use Bioprocessing Systems Market by Application
- Vaccine Production
- Biosimilar Production
- Blood Plasma Products
- Cell Therapy
- Biopharma Products
Asia Pacific Single-use Bioprocessing Systems Market by Geography
- Australia and New Zealand
- South Korea
- Southeast Asia
- Rest of APAC
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453